Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
304.00    0.50 (0.16%)
Bid:
304.00
Ask:
304.50
Spread: 0.50 (0.164%)
Market Cap: £179.47m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Directorate Change - Replacement

1 Nov 2022 16:26

RNS Number : 9709E
Treatt PLC
01 November 2022
 

 

 

1 November 2022

 

 

TREATT PLC

("Treatt" or "the Company")

 

This is a restatement of the announcement published at 10:05 on 1 November 2022 (RNS number 9039E) correcting the quote from Tim Jones to reflect that Yetunde Hofmann was Chair of the Remuneration Committee from January 2021. The full corrected announcement is below.

 

 

Board Change

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, announces that Yetunde Hofmann has informed the Board of her intention to resign as a Non-executive Director at the conclusion of the Annual General Meeting on 27 January 2023, in order to devote more time to her other board roles. 

 

Tim Jones, Chairman of Treatt, commented "I would like to express our thanks to Yetunde for her contribution to the Board and Treatt Group and for her work as Chair of the Remuneration Committee since January 2021. We wish Yetunde well for the future."

 

Following other Board changes during the year, a recruitment process is already in progress and the appointment of a new Non-executive Director will be announced in due course.

 

 

For further information please contact:

 

Treatt plc

Anita Guernari

Company Secretary

 

01284 702500

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKDBBABDDNDK
Date   Source Headline
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20255:34 pmRNSReplacement: Transaction in Own Shares
11th Apr 20252:25 pmRNSHolding(s) in Company
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20259:07 amRNSHolding(s) in Company
10th Apr 20257:01 amRNSShare Buyback Programme
10th Apr 20257:00 amRNSTrading Update
25th Mar 202511:30 amRNSVoting Rights and Capital
24th Mar 20257:00 amRNSDirectorate Change
19th Mar 20253:33 pmRNSDirector/PDMR Shareholding
6th Feb 20254:18 pmRNSHolding(s) in Company
4th Feb 202511:55 amRNSHolding(s) in Company
30th Jan 20254:17 pmRNSResult of AGM
30th Jan 20257:00 amRNSAGM Trading Update
20th Dec 202411:24 amRNSNotification of Transactions of Directors
17th Dec 20244:07 pmRNSAnnual Report and Notice of Annual General Meeting
17th Dec 20241:44 pmRNSNotification of Transactions of Directors
4th Dec 20241:47 pmRNS2024 Final Dividend
4th Dec 20247:00 amRNSFull Year Results
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
15th Nov 20247:00 amRNSBoard Change
16th Oct 202412:00 pmRNSChange in Director's Duties
10th Oct 20247:00 amRNSTrading Update
24th Sep 20242:06 pmRNSDirector/PDMR Shareholding
20th Aug 202411:06 amRNSNotification of Transactions of Directors
12th Jul 202410:49 amRNSDirector/PDMR Shareholding
4th Jun 202410:35 amRNSBlock Listing Six Monthly Return
4th Jun 202410:25 amRNSBlock Listing Six Monthly Return
3rd Jun 20247:00 amRNSDavid Shannon joins as CEO
14th May 20247:00 amRNSHalf Year Results
30th Apr 20244:02 pmRNSVoting Rights and Capital
10th Apr 20247:00 amRNSHalf Year Trading Update & Notice of Results
19th Mar 20243:40 pmRNSNotification of Transactions of Directors
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Feb 20249:35 amRNSHolding(s) in Company
31st Jan 20242:41 pmRNSNotification of Transaction of PDMR
25th Jan 20243:49 pmRNSResult of AGM
25th Jan 20247:00 amRNSAGM Trading Update
23rd Jan 20241:57 pmRNSTotal Voting Rights
21st Dec 20232:07 pmRNSNotification of Transaction of Director
15th Dec 20236:09 pmRNSNotification of Transactions - Replacement
15th Dec 20234:42 pmRNSNotification of Transactions of Directors
13th Dec 20237:00 amRNSInterim Chief Financial Officer Appointment
12th Dec 20234:24 pmRNSAnnual Report and Notice of Annual General Meeting
1st Dec 20237:01 amRNSBlock Listing Six Monthly Return
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
28th Nov 20234:15 pmRNS2023 Final Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.